December 3, 2025

NIH implements “zero-embargo” revisions to its public access policy for published scientific research

November 21, 2025

The November 2025 News from ECOG-ACRIN blog is now available

November 4, 2025

The Fall 2025 advocacy blog, Considering Clinical Trials, is now available

November 3, 2025

STAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit

October 30, 2025

WATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival

October 17, 2025

The October 2025 News from ECOG-ACRIN blog is now available

October 13, 2025

Now Enrolling: STOPGAP II trial opens for patients with stomach cancer

October 13, 2025

Institution Spotlight: Delaware/ChristianaCare NCORP

October 3, 2025

Biomarker breakthroughs at ASTRO 2025 (features a discovery from the E3805 CHAARTED prostate cancer trial)

ECOG-ACRIN Cancer Research Group